Global Ischemic Heart Disease (IHD) Drugs Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

Segmented by Disease Class;

Angina Pectoris - Stable Angina, Unstable Angina and Prinzmetal's Angina, Mi - Stemi and Nstemi.

Segmented by Drug Class;

Anti-dyslipidemic Drugs, Calcium Channel Blockers, Beta-blockers, ACE Inhibitors, ARBs, Vasodilators and Antithrombotic Agents.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2017 - 2027).
Report ID: Rn111162839 Published Date: December, 2021 Updated Date: January, 2022

Introduction

Global Ischemic Heart Disease (IHD) Drugs Market (USD Million), 2017 - 2027

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2017 - 2027
2017 83.0
2018 92.7
2019 111.0
2020 115.0
2021 123.6
2022 130.6
2023 152.4
2024 156.3
2025 162.7
2026 173.9
2027 185.7

In the year 2020, the Global Ischemic Heart Disease (IHD) Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Disease Class
    2. Market Snapshot, By Drug Class
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Ischemic Heart Disease (IHD) Drugs Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rise in Number of Patients
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Ischemic Heart Disease (IHD) Drugs Market, By Disease Class, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2021 and 2027 (%)
      3. Y-o-Y Growth Analysis, 2018 - 2027
      4. Segment Trends
        1. Angina Pectoris
          1. Introduction
          2. Market Share Analysis, 2021 and 2027 (%)
          3. Y-o-Y Growth Analysis, 2018 - 2027
          4. Segment Trends
            1. Stable Angina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
            2. Unstable Angina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
            3. Prinzmetal's Angina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        2. Mi
          1. Introduction
          2. Market Share Analysis, 2021 and 2027 (%)
          3. Y-o-Y Growth Analysis, 2018 - 2027
          4. Segment Trends
            1. Stemi
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
            2. Nstemi
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
    2. Global Ischemic Heart Disease (IHD) Drugs Market, By Drug Class, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2021 and 2027 (%)
      3. Y-o-Y Growth Analysis, 2018 - 2027
      4. Segment Trends
        1. Anti-dyslipidemic Drugs
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        2. Calcium Channel Blockers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        3. Beta-blockers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        4. ACE Inhibitors
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        5. ARBs
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        6. Vasodilators
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        7. Antithrombotic Agents
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
    3. Global Ischemic Heart Disease (IHD) Drugs Market, By Geography, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2021 and 2027 (%)
      3. Y-o-Y Growth Analysis, 2018 - 2027
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. AstraZeneca
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Bayer
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Eli Lilly
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Novartis
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Pfizer
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Sanofi
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Healthcare IT IT Spending On Clinical Analytics
Global IT Spending On Clinical Analytics Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

In the year 2020, the Global IT Spending On Clinical Analytics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices IV Bags
Global IV Bags Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

In the year 2020, the Global IV Bags Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices IV Equipment
Global IV Equipment Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

In the year 2020, the Global IV Equipment Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Joint Replacement
Global Joint Replacement Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

In the year 2020, the Global Joint Replacement Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...